In Brief: Boston Scientific/CardioGenesis
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific/CardioGenesis: Boston Scientific gains exclusive international rights to sell and distribute "the full range" of CardioGenesis' transmyocardial revascularization products. CardioGenesis says Boston Scientific will form "a dedicated sales force" in Europe for its myocardial revascularization products...